Online:
Visits:
Stories:
Profile image
Story Views

Now:
Last Hour:
Last 24 Hours:
Total:

Chimeric Antigen Receptor (CAR) T cell Immunotherap Market Size, Share, Company Profile, Analysis and Forecasts To 2021

Friday, February 17, 2017 3:39
% of readers think this story is Fact. Add your two cents.

(Before It's News)

Chimeric Antigen Receptor (CAR) T cell Immunotherapy- Competitive Landscape, Technology and Pipeline Analysis, 2017 emphasizes on the currently active CAR-T cell products in research and development. The Report covers the 35+ companies which are active in this field including 14 leading companies with 35 products targeting 20 different antigens and 9 different technologies. The Report provides in-depth analysis on the CAR-T cell profiles covering pre-clinical and clinical studies, Collaborations details and Deal values, Technologies and Targeted antigens. The Report provides the CAR-T licensing opportunities, acquisitions, market drivers and barriers followed by SWOT Analysis. Report also describes the unmet needs covered by CAR-T cells highlighting the adverse events, which are major concerns in the market for the usage of CAR-T cells.

Direct Purchase Full Report @ https://marketreportscenter.com/buy-now?sku=DIFEB161701

Report Highlights:

CAR-T cell Therapy Pipeline scenario
Collaborations & partnering deals
Current Prominent Research Areas and Key Players
Pipeline product profiles CAR-T Technologies and Targeted Antigens
Licensing opportunities
Market Drivers and Barriers

Scope

Overview of the global CAR-T cell therapy pipeline scenario, products and associated companies information

Coverage of global CAR-T cell therapies under development

Competitive landscape of products for key players and related indications

Coverage of licensors, collaborators and Development partners, deal terms and deal values estimation

Pipeline analysis across different phases, emerging trends and comparative analysis of pipeline products with detailed clinical profiles, mechanism of action, route of administration and molecule type, along with product development activities

Highlights of licensing & collaboration opportunities and funding details

Highlights of latest CAR-T technologies and innovative companies

Key topics covered include strategic competitor assessment, barriers and drivers in the market along with SWOT analysis

Key Topics;

CAR-T cell Therapy Pipeline scenario

Current Prominent Research Areas and Key Players

Collaborations details and Deal values

Technologies and Targeted antigens

Pipeline product profiles CAR-T Technologies and Targeted Antigens

Licensing opportunities 

Market Drivers and Barriers

SWOT Analysis

Complete Report Details @ https://marketreportscenter.com/reports/509285/chimeric-antigen-receptor-car-t-cell-immunotherapy-competitive-landscape-technology-and-pipeline-analysis-2017

Table of Content

1 Report Introduction

2 Executive Summary Snapshot

3 Executive Summary

4 Introduction

4.1. Chimeric antigen receptor (CAR) T-cells

4.2. History

4.3. CARs and Generations

4.4. Advantages of CAR-T cells

4.5. Adverse Events with CAR T-cell Therapy

5 Car-T Cell Therapy-Analysis

5.1. CAR-T Collaboration Deals

5.1.1. CAR-T Cells Therapy Collaborations and Deal Year

5.1.2. Collaborations & Deal Value Trends

5.1.3. Companies collaborations for future developments

5.2. CAR-T Acquisitions Deals

5.2.1. CAR-T Cells Therapy Acquisitions Trends

5.2.2. CAR-T Cells Therapy Acquisitions Offerings by Big Giants

5.3. New facility for the development of CAR-T cells

5.4. CAR-T Licensing Opportunities

5.5. Pipeline Scenario

5.5.1. Pipeline Products under Development-An Overview

5.5.2. Pipeline Products under Development by Company

5.5.3. CAR T-cells Therapeutic Areas & Companies

5.5.4. CAR-T cells Targeted Antigens

5.5.5. CAR-T Therapies-Clinical trials & Completion Year

5.5.6. CAR T-cell Technologies & Companies Involved

5.5.7. CAR-T Safety Switches & Company involved

6 Pipeline Profiles

7 Market Drivers

8 Market Barriers

9 SWOT Analysis

10 Report Methodology

11 Consulting Services

Discount On This Report @ https://marketreportscenter.com/request-discount/509285

For more information, please visit https://marketreportscenter.com

For more information content with us;

Sam Collins

Market Reports Center 1-646-883-3044 (US)

info@marketreportscenter.com

https://marketreportscenter.com

Source: https://marketreportscenter.com/reports/509285/chimeric-antigen-receptor-car-t-cell-immunotherapy-competitive-landscape-technology-and-pipeline-analysis-2017

 

Report abuse

Comments

Your Comments
Question   Razz  Sad   Evil  Exclaim  Smile  Redface  Biggrin  Surprised  Eek   Confused   Cool  LOL   Mad   Twisted  Rolleyes   Wink  Idea  Arrow  Neutral  Cry   Mr. Green

Top Stories
Recent Stories
 

Featured

 

Top Global

 

Top Alternative

 

Register

Newsletter

Email this story
Email this story

If you really want to ban this commenter, please write down the reason:

If you really want to disable all recommended stories, click on OK button. After that, you will be redirect to your options page.